Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 4, 1998, Pages 325-329

  Montes, Miguel A ^a   Fox, Edward A ^a   Longtine, Janina A ^a   Dorfman, David M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENETIC SCREENING; HUMAN; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PREDICTION; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BLOOD COAGULATION DISORDERS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE; FACTOR V; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POINT MUTATION; PROTEIN C;

EID: 0031891915     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369: 64-67.
2. Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in factor V(R506Q). J Biol Chem. 1995;270:4053-4057.
3. 506-FactorV. Blood. 1995;85:3405-3411.
4. Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same Factor V gene mutation in 47 of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994;94:2521-2524.
5. Svennson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522.
6. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and Factor V Leiden as risk factors for venous thrombosis. Thromb Haemost. 1995;74:449-453.
7. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for Factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
8. De Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 1994;72:880-886.
9. Hirsch DR, Mikkola KM, Marks PW, Fox EA, Dorfman DM, Ewenstein BM, Goldhaber SZ. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J. 1996;131:1145-1148.
10. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503-1506.
11. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. Touchdown PCR to circumvent spurious priming during gene amplification. Nucl Acids Res. 1991;19:4008-4009.
12. Bauer KA. Natural anticoagulants and the prethrombotic state. In: Handin RI. Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia, Pa: JB Lippincott Co; 1995:1319-1339.
13. Voelkerding KV, Wu L, Williams EC, et al. Factor V R506Q gene mutation analysis by PCR-RFLP: optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls. Am J Clin Pathol. 1996;106:100-106.
14. Zehnder JL, Benson RC. Sensitivity and specificity of the APC resistance assay in detection of individuals with Factor V Leiden. Am J Clin Pathol. 1996; 106:107-111.
15. Legani C, Palareti C, Biagi R, et al. Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haematol. 1996;93:694-699.
16. Le DT, Griffin JH, Greengard JS, Mujumdar V, Rapaport SI. Use of a generally applicable tissue factor-dependent Factor V assay to detect activated protein C-resistant Factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood. 1995;85:1704-1711.
17. Kapiotis S, Quehenberger P, Jilma B, et al. Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of amples with Factor V deficient plasma. Am J Clin Pathol. 1996;106:588-593.